Our large-scale multi-omics analyses give you an unprecedented view into the factors that modulate health, disease, and drug response across individuals and over time.
Sapient is a purpose-built biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis.
Sapient’s next-generation, high throughput mass spectrometry systems capture diverse metabolite and lipid chemistries in a single run.
Sapient’s mass spectrometry-based discovery proteomics method extends multi-omics insights with deep coverage of the blood and tissue proteome.
Through our integrated multi-omics services, we generate greater biological insight from every sample to help you better understand disease and accelerate drug development.
We offer expert data analysis services to help you map the genetic and phenotypic associations of your identified biomarkers.
Our team uses advanced statistical and ML tools to amalgamate multi-omics, preclinical, and clinical data with human health metadata.
Using Sapient’s proprietary Human Biology Database, comprised of data from 100K+ biosamples with paired genetic, phenotypic, and clinical information.
Sapient was founded on a core set of discovery values that we bring to every client collaboration, and that we believe are critical to accelerate drug development success.
We know our data drives your
decision-making and have capacity to ensure fast turnaround of results.
We believe it essential that you have full access to and ownership of your data and findings.
We utilize novel technologies and deep expertise to assay thousands of dynamic, non-genetic biomarkers.
Connect with our scientists to discuss your project or the biological questions you want to answer. We’re here to help you apply robust, creative omics approaches at any phase of development.